Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

StockCall Pre-Market Review on BAX, CFN, UNIS, and MR

BAX
StockCall Pre-Market Review on BAX, CFN, UNIS, and MR

StockCall.com Provides Stock Research on Baxter Intl. Inc., CareFusion Corp., Unilife Corp., and Mindray Medical Intl. Ltd.

New York City, New York -- (May 30, 2013)

The healthcare sector in the U.S. is undergoing major transformation as the Affordable Care Act (ACA) goes into effect. The ACA is the biggest overhaul of the healthcare industry in the U.S, and while it has generally been welcomed by the healthcare sector, some features of the legislation have been criticized. One of the most controversial features of the ACA has been the 2.3% tax on U.S. gross sales of medical devices which will be levied on medical instruments & supplies companies. The industry says that the tax will result in higher costs, and therefore hurt innovation. Shares in medical instruments & supplies companies ended mostly lower on Wednesday, May 29, 2013, tracking losses in the broader market. The major movers in the sector included Baxter International Inc. (NYSE: BAX), CareFusion Corporation (NYSE: CFN), Unilife Corp. (NASDAQ: UNIS), and Mindray Medical International Ltd. (ADR) (NYSE: MR).StockCall analysts initiated preliminary technical research on BAX, CFN, UNIS, and MR. These free reports are accessible by signing today at

www.stockcall.com/register

Shares in Baxter International Inc. fell sharply on Wednesday, closing 1.34% lower at $71.34 after trading between $70.85 and $72.03. A total of 2.37 million shares were traded which is well below the daily average volume of 4.26 million. So far this year, company shares have gained over 7.70%, underperforming the S&P 500. The stock is currently trading 3.53% below its 52-week high. It currently faces resistance at around $73. Shares of BAX are currently trading above their 50- and 200-day moving averages. The free technical analysis on BAX is available by signing up at

www.StockCall.com/BAX053013.pdf

CareFusion Corporation’s stock slipped in the last session, reversing some of the gains from previous trading days. The company’s shares traded between $34.37 and $35.04 before finishing the day 0.23% lower at $34.82. A total of 2.10 million shares were exchanged which is above the daily average volume of 1.97 million. However, despite the losses on Wednesday, shares of CFN are still up nearly 1.20% in the last three sessions. The stock is also trading above its 50- and 200-day moving averages. Register now to download the free research on CFN at

www.StockCall.com/CFN053013.pdf

Shares in Unilife Corp. tumbled on Wednesday, closing 10.59% lower at $3.46. A total of 2.07 million shares were traded which is well above the daily average volume of 1.72 million. The company’s shares traded between $3.34 and $3.89. However, despite the significant losses yesterday, the stock is still up over 52.40% so far in 2013, outperforming the S&P 500. Shares of UNIS are still trading 33.08% below their 52-week high. The stock is currently trading well above its 50- and 200-day moving averages. Free report on UNIS can be accessed by registering at

www.StockCall.com/UNIS053013.pdf

Mindray Medical International Ltd’s stock ended slightly lower yesterday, finishing at $41.23, down 0.39% from previous session’s closing price. A total of 951,985 shares were exchanged which is well above the daily average volume of 775,902. The company’s shares traded between $40.97 and $41.25 on Wednesday. The stock is currently hovering close to its 52-week high of $42.40. So far this year, shares of MR have gained over 27.70%, outperforming the S&P 500. The stock currently faces resistance at around $42.Register withStockCall and download the research on MR for free at

www.StockCall.com/MR053013.pdf

About StockCall.com

StockCall.com is a financial website where investors can have easy, precise and comprehensive research and opinions on stocks making the headlines. Sign up today to talk to our financial analyst at

www.stockcall.com

Contact Person:

William T. Knight

Email: info@stockcall.com

Contact Number: (646) 396-9857 (9:00 am EST – 01:30 pm EST)



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today